Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT00505895Phase 2Completed
FM 140 vs FM100 Study in Patients With Multiple Myeloma
Multiple Myeloma
Principalinvestigator
NCT01079936Phase 1/2Completed
Lenalidomide and High-Dose Melphalan
MyelomaStem Cell Transplantation
Studychair

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveStem Cell Transplantation
Similarity Score23%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMultiple Myeloma
Similarity Score15%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMultiple Myeloma
Similarity Score15%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMultiple Myeloma
Similarity Score15%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score15%

Richard E. Champlin, MD, BS

UT MD Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Worked with same sponsors:

M.D. Anderson Cancer Center
Collaborated on 1 trial
Similarity Score14%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Similarity Score8%

Meral Boşnak Güçlü, PhD

Gazi University

Related
10 trials

Shared therapeutic areas:

Stem Cell Transplantation
Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Multiple Myeloma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00505895Phase 2PrincipalInvestigator

FM 140 vs FM100 Study in Patients With Multiple Myeloma

Multiple Myeloma
Completed
NCT00866346Phase 1PrincipalInvestigator

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Chronic Myelogenous Leukemia
Withdrawn
NCT01079936Phase 1/2StudyChair

Lenalidomide and High-Dose Melphalan

MyelomaStem Cell Transplantation
Completed

All 3 trials loaded